Skip to content

Clinical trials

Completed Phase 2 Respiration Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiration Disorders Phase: Phase 2 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20105
20111
20142
20171
20181
20191
20203
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
GlaxoSmithKline4
Göteborg University2
Altesa Biosciences, Inc.1
Catalysis SL1
Columbia University1
Debiopharm International SA1
Northwestern University1
R-Pharm1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiration Disorders21
Pulmonary Disease, Chronic Obstructive11
Lung Diseases7
Bronchiolitis Obliterans Syndrome4
Respiratory Tract Diseases3
Apnea2
COVID-192
Emphysema2
Respiratory Tract Infections2
Sleep Apnea Syndromes2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.